Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Stoke Therapeutics
3 Preston Court, Suite 102
Bedford, MA 01730
Phone: 781-430-8200
https://www.stoketherapeutics.com/

Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the central nervous system, eye, and liver. Stoke was launched in 2018 with a $40 million Series A investment funded by Apple Tree Partners.

Key Contact
Name
Edward M. Kaye, M.D.
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/04/18 $40,000,000 Series A Apple Tree Partners
undisclosed
10/23/18 $90,000,000 Series B Alexandria Venture Investments
Apple Tree Partners
Cormorant Asset Management
Janus Henderson Investors
Perceptive Advisors
RA Capital Management
Redmile Group
RTW Investments
Sphera Funds Management
undisclosed